Inventor · disambiguated record
Yasmina Noubia Abdiche
Also filed as: ABDICHE YASMINA · ABDICHE YASMINA NOUBIA
25 granted patents·7 pending applications·667 citations·filing 2006–2023
97Inventor score
Files withTEVA PHARMACEUTICALS INT GMBH10LABRYS BIOLOG INC8RINAT NEUROSCIENCE CORP7LIANG HONG3TALEM THERAPEUTICS LLC2
Top patents by PatentIndex Score
32 records- 0198US8734802B1Methods of treating vasomotor symptoms using antibodiesLABRYS BIOLOG INC·Filed 2013·Granted May 27, 2014·54 cites·20 claims
- 0298US8597649B2Antagonist antibodies directed against calcitonin gene-related peptide and methods using sameLABRYS BIOLOG INC·Filed 2013·Granted Dec 3, 2013·51 cites·9 claims
- 0397US9884907B2Methods for treating headache using antagonist antibodies directed against calcitonin gene-related peptideTEVA PHARMACEUTICALS INT GMBH·Filed 2017·Granted Feb 6, 2018·15 cites·18 claims
- 0497US9884908B2Methods for treating headache using antagonist antibodies directed against calcitonin gene-related peptideTEVA PHARMACEUTICALS INT GMBH·Filed 2017·Granted Feb 6, 2018·15 cites·18 claims
- 0597US9346881B2Antagonist antibodies directed against calcitonin gene-related peptide and methods using sameLABRYS BIOLOG INC·Filed 2015·Granted May 24, 2016·16 cites·19 claims
- 0697US9340614B2Antagonist antibodies directed against calcitonin gene-related peptide and methods using sameLABRYS BIOLOG INC·Filed 2015·Granted May 17, 2016·16 cites·20 claims
- 0797US9266951B2Antagonist antibodies directed against calcitonin gene-related peptide and methods using sameLABRYS BIOLOG INC·Filed 2015·Granted Feb 23, 2016·23 cites·19 claims
- 0897US9115194B2Antagonist antibodies directed against calcitonin gene-related peptide and methods using sameLABRYS BIOLOG INC·Filed 2014·Granted Aug 25, 2015·26 cites·20 claims
- 0997US8080243B2Isolated antibody which specifically binds to PCSK9LIANG HONG·Filed 2009·Granted Dec 20, 2011·139 cites·3 claims
- 1097US8007794B2Antagonist antibodies directed against calcitonin gene-related peptide and methods using sameRINAT NEUROSCIENCE CORP·Filed 2006·Granted Aug 30, 2011·51 cites·9 claims
- 1196US9890210B2Antagonist antibodies directed against calcitonin gene-related peptideTEVA PHARMACEUTICALS INT GMBH·Filed 2017·Granted Feb 13, 2018·11 cites·15 claims
- 1296US9890211B2Antagonist antibodies directed against calcitonin gene-related peptideTEVA PHARMACEUTICALS INT GMBH·Filed 2017·Granted Feb 13, 2018·11 cites·15 claims
- 1396US9365648B1Methods of using anti-CGRP antagonist antibodiesLABRYS BIOLOG INC·Filed 2016·Granted Jun 14, 2016·16 cites·29 claims
- 1496US9328168B2Methods of using anti-CGRP antagonist antibodiesLABRYS BIOLOG INC·Filed 2015·Granted May 3, 2016·16 cites·30 claims
- 1596US8586045B2Methods of using anti-CGRP antagonist antibodiesZELLER JOERG·Filed 2011·Granted Nov 19, 2013·61 cites·31 claims
- 1696US8426363B2Method for reducing a level of LDL-cholesterol by an antibody that specifically binds to PCSK9LIANG HONG·Filed 2011·Granted Apr 23, 2013·58 cites·13 claims
- 1796US8399646B2Isolated nucleic acid encoding an antibody which specifically binds to PCSK9 and a host cell that produces the antibodyLIANG HONG·Filed 2011·Granted Mar 19, 2013·57 cites·14 claims
- 1894US10155037B2Anti-PD-1 antibodies and methods of use thereofRINAT NEUROSCIENCE CORP·Filed 2015·Granted Dec 18, 2018·18 cites·45 claims
- 1993US10329343B2Methods for treating headache using antagonist antibodies directed against calcitonin gene-related peptideTEVA PHARMACEUTICALS INT GMBH·Filed 2018·Granted Jun 25, 2019·5 cites·24 claims
- 2090US2024158481A1Antagonist Antibodies Directed Against Calcitonin Gene-Related Peptide and Methods Using SameTEVA PHARMACEUTICALS INT GMBH·Filed 2023·Application pending·0 cites
- 2186US9175093B2PCSK9 antagonistsRINAT NEUROSCIENCE CORP·Filed 2013·Granted Nov 3, 2015·6 cites·11 claims
- 2285US10660953B2Anti-PD-1 antibodies and methods of use thereofRINAT NEUROSCIENCE CORP·Filed 2018·Granted May 26, 2020·2 cites·19 claims
- 2379US2022056114A1Antagonist Antibodies Directed Against Calcitonin Gene-Related Peptide and Methods Using SameTEVA PHARMACEUTICALS INT GMBH·Filed 2021·Application pending·0 cites
- 2478US2020247878A1Antagonist Antibodies Directed Against Calcitonin Gene-Related Peptide and Methods Using SameTEVA PHARMACEUTICALS INT GMBH·Filed 2019·Application pending·0 cites
- 2576US2022249657A1Anti-pd-1 antibodies and methods of use thereofRINAT NEUROSCIENCE CORP·Filed 2022·Application pending·0 cites
- 2672US2019092841A1Antagonist Antibodies Directed Against Calcitonin Gene-Related Peptide and Methods Using SameTEVA PHARMACEUTICALS INT GMBH·Filed 2018·Application pending·0 cites
- 2770US11338035B2Anti-PD-1 antibodies and methods of use thereofRINAT NEUROSCIENCE CORP·Filed 2020·Granted May 24, 2022·0 cites·15 claims
- 2866US2017081395A1Antagonist antibodies directed against calcitonin gene-related peptide and methods using sameTEVA PHARMACEUTICALS INT GMBH·Filed 2016·Application pending·0 cites
- 2960US12037383B2Anti-spike glycoprotein antibodies and the therapeutic use thereofTALEM THERAPEUTICS LLC·Filed 2023·Granted Jul 16, 2024·0 cites·30 claims
- 3056US11623949B2Anti-spike glycoprotein antibodies and the therapeutic use thereofTALEM THERAPEUTICS LLC·Filed 2022·Granted Apr 11, 2023·0 cites·30 claims
- 3155US10825548B2Systems and methods of sensing and analyzing antibody blocking interactionsWASATCH MICROFLUIDICS INC·Filed 2014·Granted Nov 3, 2020·0 cites·36 claims
- 3254US2016096898A1Pc33718eRINAT NEUROSCIENCE CORP·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yasmina Noubia Abdiche files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →